| | Early EPCs | Late EPCs |
| Synonyms | CACs [82] | OECs [83, 91] or ECFCs [84] | Cell population [81, 91] | Heterogeneous | Homogenous | Cell morphology [81] | Spindle-shaped cells | Cobblestone-like cells | Appearance in culture | <1 week [5, 81] | 2–4 weeks [81] | Lifespan [81] | 3-4 weeks | ≈12 weeks | Morphogenic potential [81] | Low | High | Angiogenic potential [81] | Good | Good | Tube formation in vitro [5, 92, 134] | Tube formation by EPCs alone | Absent | Present | Tube formation by EPCs with HUVECs | Absent | Present | Tube formation in vivo [92] | Absent | Present | Neovascularization in vivo [82, 92, 93, 134] | Indirect paracrine fashion | Directly providing ECs; hence can be referred to as “true EPCs” | Surface expression | CD34 [88, 134] | + | + | CD45 [81, 88, 134] | + | − | CD14 | + and − [91, 93]/+ [92] | − | CD133 | − [88] and + [89, 136] | − [88, 89, 136] | CD31 (PECAM 1) [81, 134, 137] | −/+ | ++ | VEGFR-2 [81, 92, 93, 134, 137] | −/+ | ++ | VE cadherin [81, 93, 134] | −/+ | ++ | vWf [81] | −/+ | + | Phenotype [90] | Monocytic | Endothelial | AcLDL uptake [5] | + | ++ | Lectin binding [5] | + | ++ | NO production [5] | + | ++ |
|
|